StockNews.com upgraded shares of Nu Skin Enterprises (NYSE:NUS - Free Report) from a hold rating to a buy rating in a research report report published on Monday morning.
Nu Skin Enterprises Stock Performance
Shares of Nu Skin Enterprises stock traded up $0.15 on Monday, reaching $7.47. 326,417 shares of the stock were exchanged, compared to its average volume of 835,161. The firm has a market capitalization of $371.43 million, a PE ratio of -2.53 and a beta of 0.92. Nu Skin Enterprises has a 1-year low of $5.32 and a 1-year high of $13.90. The business has a fifty day moving average price of $6.68 and a two-hundred day moving average price of $6.97. The company has a current ratio of 1.82, a quick ratio of 1.17 and a debt-to-equity ratio of 0.56.
Nu Skin Enterprises (NYSE:NUS - Get Free Report) last issued its earnings results on Thursday, May 8th. The company reported $0.23 EPS for the quarter, topping the consensus estimate of $0.15 by $0.08. Nu Skin Enterprises had a negative net margin of 8.46% and a positive return on equity of 5.86%. The company had revenue of $364.49 million for the quarter, compared to analyst estimates of $352.06 million. As a group, research analysts anticipate that Nu Skin Enterprises will post 1.05 earnings per share for the current fiscal year.
Nu Skin Enterprises Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 11th. Shareholders of record on Friday, May 30th will be issued a $0.06 dividend. The ex-dividend date of this dividend is Friday, May 30th. This represents a $0.24 dividend on an annualized basis and a yield of 3.21%. Nu Skin Enterprises's dividend payout ratio (DPR) is -30.00%.
Hedge Funds Weigh In On Nu Skin Enterprises
Several institutional investors and hedge funds have recently bought and sold shares of NUS. JPMorgan Chase & Co. grew its stake in Nu Skin Enterprises by 175.6% during the third quarter. JPMorgan Chase & Co. now owns 231,957 shares of the company's stock worth $1,710,000 after buying an additional 147,784 shares during the period. Bank of Montreal Can acquired a new position in shares of Nu Skin Enterprises during the 4th quarter valued at $80,000. AlphaQuest LLC boosted its position in Nu Skin Enterprises by 197.8% during the 4th quarter. AlphaQuest LLC now owns 108,204 shares of the company's stock worth $746,000 after purchasing an additional 71,864 shares during the period. MetLife Investment Management LLC increased its holdings in Nu Skin Enterprises by 36.2% in the 4th quarter. MetLife Investment Management LLC now owns 30,429 shares of the company's stock valued at $210,000 after purchasing an additional 8,091 shares in the last quarter. Finally, Barclays PLC raised its position in Nu Skin Enterprises by 363.8% in the third quarter. Barclays PLC now owns 85,437 shares of the company's stock valued at $629,000 after purchasing an additional 67,016 shares during the period. Institutional investors and hedge funds own 82.84% of the company's stock.
About Nu Skin Enterprises
(
Get Free Report)
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
See Also
Before you consider Nu Skin Enterprises, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.
While Nu Skin Enterprises currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
